These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 570148)

  • 21. Effects of prostaglandin inhibition on vasopressin levels in women with primary dysmenorrhea.
    Strömberg P; Forsling ML; Akerlund M
    Obstet Gynecol; 1981 Aug; 58(2):206-8. PubMed ID: 7254732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preterm labour.
    Roopnarinesingh S; Manjoo R; Matadial L
    West Indian Med J; 1983 Dec; 32(4):201-6. PubMed ID: 6145254
    [No Abstract]   [Full Text] [Related]  

  • 23. [Symptomatic therapy of primary dysmonorrhea by inhibition of prostaglandin synthesis with indomethacin (author's transl)].
    Cornely M; Beutnagel H; Schönhöfer PS
    Geburtshilfe Frauenheilkd; 1978 Jan; 38(1):18-24. PubMed ID: 627337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandins in reproduction.
    Moghissi KS
    Obstet Gynecol Annu; 1972; 1(0):297-337. PubMed ID: 4599616
    [No Abstract]   [Full Text] [Related]  

  • 25. On the use of blockers of prostaglandin synthesis in the control of labor.
    Karim SM
    Adv Prostaglandin Thromboxane Res; 1978; 4():301-6. PubMed ID: 347913
    [No Abstract]   [Full Text] [Related]  

  • 26. New concepts in dysmenorrhea.
    Ylikorkala O; Dawood MY
    Am J Obstet Gynecol; 1978 Apr; 130(7):833-47. PubMed ID: 25021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of dysmenorrhea with a new prostaglandin antagonist].
    Scarrone G; Cabiati E; Maggio G; Furbatto G
    Minerva Ginecol; 1982 Dec; 34(12):1047-50. PubMed ID: 7155437
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary dysmenorrhea: pathogenesis and therapy.
    Kulig JW
    Conn Med; 1982 Mar; 46(3):123-5. PubMed ID: 7075181
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic aspects of prostaglandin research in gynecology].
    Lippert TH
    Geburtshilfe Frauenheilkd; 1972 Jan; 32(1):13-9. PubMed ID: 4622091
    [No Abstract]   [Full Text] [Related]  

  • 30. Menstrual pain: its origin and pathogenesis.
    Rosenwaks Z; Seegar-Jones G
    J Reprod Med; 1980 Oct; 25(4 Suppl):207-12. PubMed ID: 7001019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience with the treatment of primary dysmenorrhea].
    Horváth B; Turay A; Horváth S
    Orv Hetil; 1981 Apr; 122(14):823-5. PubMed ID: 7254808
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prostaglandins and diarrhea].
    Sabán Ruiz J; Boixeda de Miguel D; Moreira Vicente V; Serrano Ríos M
    Med Clin (Barc); 1984 Nov; 83(14):600-5. PubMed ID: 6392769
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prostaglandins: physiological or "foreign" molecules? Some ticklish questions. Biosynthesis. Nutrition. Pathology (author's transl)].
    Devis R
    J Pharm Belg; 1981; 36(1):43-72. PubMed ID: 7014826
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary dysmenorrhea.
    Abraham GE
    Clin Obstet Gynecol; 1978 Mar; 21(1):139-45. PubMed ID: 630748
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostaglandin inhibitors for primary dysmenorrhea.
    Sasso SC
    MCN Am J Matern Child Nurs; 1984; 9(3):177. PubMed ID: 6425593
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo evidence for prostaglandin inhibitory activity in New Zealand green-lipped mussel extract.
    Miller T; Wu H
    N Z Med J; 1984 Jun; 97(757):355-7. PubMed ID: 6589519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism and prevention of preterm birth.
    Fuchs AR; Fuchs F
    Prog Clin Biol Res; 1985; 163B():223-30. PubMed ID: 2858861
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibition of labour. Symposium by letter (author's transl)].
    Hüter J; Baumgarten K; Jung H; Melchior J; Mosler KH; Weidinger H
    Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):689-98. PubMed ID: 4155045
    [No Abstract]   [Full Text] [Related]  

  • 39. [Risks of simultaneous tocolytic treatment with beta adrenergic and PG inhibiting agents].
    Reimann IW; Frölich JC
    Z Geburtshilfe Perinatol; 1981 Dec; 185(6):305-12. PubMed ID: 6122312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of premature birth.
    Fuchs F
    Clin Perinatol; 1980 Mar; 7(1):3-15. PubMed ID: 6105033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.